FDA Inspection 777939 — Linde Inc.

Linde Inc. — FEI 1312847

The FDA completed an inspection of Linde Inc. on Apr 11, 2012 in Niagara Falls, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 11, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Niagara Falls, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.